● A free public tool  ·  Built by Poptani Labs  ·  No sign-up  ·  Your data never leaves your browser
Beyond the Hype · 5-minute read

Do brain-training apps work? What the evidence actually says

A medical illustration of the human brain, with the striatum highlighted
Image: 'Brain Anatomy Striatum.png' by BruceBlaus, CC BY-SA 4.0, via Wikimedia Commons

Brain-training apps make a neat promise: a few minutes of games a day, and you will get a sharper memory, better focus at work, and a brain that ages more slowly. Lumosity, the biggest name in the field, attracted more than 85 million users across 180 countries. Then, in January 2016, its maker, Lumos Labs, paid $2 million to settle charges from the US Federal Trade Commission. This is a research-based look at what the evidence actually says — no hands-on testing, just the studies and the regulatory record.

What the FTC actually found

The FTC's charge was deceptive advertising. The agency said Lumosity had claimed its games would improve performance at work, school, and athletics; delay age-related cognitive decline; and reduce impairment from conditions including stroke, traumatic brain injury, PTSD, ADHD, dementia, and Alzheimer's — and that scientific studies proved it. They didn't have the science. The FTC's Bureau of Consumer Protection director, Jessica Rich, put it plainly: Lumosity “preyed on consumers' fears about age-related cognitive decline.” The settlement imposed a $50 million judgment, suspended after the $2 million payment, and required the company to obtain human clinical testing before making broad cognition claims in the future. It is the clearest signal of where the line is for what a brain app can claim.

Near transfer is real. Far transfer mostly isn't.

The core problem is a concept called transfer. Near transfer means getting better at the trained task, or at very similar ones — and that part is real. People who play Lumosity get better at Lumosity. Far transfer means those gains spreading to unrelated abilities: general intelligence, focus at work, everyday memory. That is where the evidence thins out. The largest single test was run by Adrian Owen and colleagues and published in Nature in 2010: 11,430 people completed six weeks of online cognitive training on reasoning, memory, planning, and attention tasks. They improved on every task they trained — but those gains did not transfer to untrained tasks, even closely related ones. The authors' conclusion, verbatim, was that the results “provide no evidence to support the widely held belief that the regular use of computerized brain trainers improves general cognitive functioning in healthy participants beyond those tasks that are actually being trained.”

The reviews agree — with one exception

The big reviews tell the same story. Daniel Simons and six colleagues reviewed more than 130 studies in 2016, including those cited by brain-game companies, and concluded that people improve on trained tasks, less on closely related tasks, and there is very little evidence of improvement on distant tasks or in everyday life. A separate 2016 meta-analysis of 87 publications found no convincing evidence that working-memory training improves intelligence, reading, or arithmetic. And in 2014, roughly 70 neuroscientists and psychologists, convened by the Stanford Center on Longevity and the Berlin Max Planck Institute for Human Development, signed a consensus statement saying there was no compelling evidence that brain games improve everyday cognition or stave off decline. There is, however, one genuine exception. The ACTIVE trial enrolled about 2,800 adults aged 65 and over from 1998, randomised to reasoning, speed, or memory training, or a control group. In February 2026, researchers linked participants to Medicare records through 2019 and found that those who did speed training with booster sessions were about 25 percent less likely to be diagnosed with dementia than the control group. The memory and reasoning groups showed no significant difference — and it comes from a single trial, so no app can claim to prevent dementia. In December 2025, the FDA cleared LumosityRx, a prescription app for adults aged 22 to 55 with ADHD — a regulated medical product, not a consumer brain game.

So is it worth paying for?

For most healthy adults, no — if the goal is getting smarter, sharper at work, or protected against cognitive decline. Lumosity's own randomised study of 4,715 people found that after 10 weeks, Lumosity users improved more than a crossword-puzzle group on its own assessments — which is near transfer again: better at the test, not necessarily better at life. The apps are not useless; they are games, and games are enjoyable, and enjoying a puzzle is a perfectly good reason to play one. The problem was never the games. It was the promise attached to them — that a few minutes of tapping could buy you a better brain. The evidence says it buys you a better score.

Verdict

A brain-training app is worth paying for when you know what you are buying: a set of puzzles you enjoy. It is not worth it as a general promise of a sharper mind, and the $2 million FTC settlement is the receipt for that promise. The cheapest way to keep your brain in shape is still the least exciting one — and no app has found a shortcut around it.

Related on Poptani Labs: Blue-light glasses: the cheap fix your tired eyes probably don't need, The sunk-cost fallacy: why you finish the bad movie, The Proust effect: why one smell can time-travel you back. More in this category: Beyond the Hype.

Sources: NeuroLaunch, Lumosity Brain Training, Memo, Do Brain Training Apps Work? What the Evidence Says, Deadline, Is Lumosity Worth It? An Honest 2026 Verdict

← All posts